{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:42:05Z","timestamp":1787740925035,"version":"build-2784847793"},"reference-count":31,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"RAS LR7, 2017","award":["RASSR14371"],"award-info":[{"award-number":["RASSR14371"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Topical psoralens plus ultraviolet A radiation (PUVA) therapy consists in the topical application of 8-methoxypsoralen (8-MOP) followed by the skin irradiation with ultraviolet A radiation. The employment of classical 8-MOP vehicles in topical PUVA therapy is associated with poor skin deposition and weak skin permeability of psoralens, thus requiring frequent drug administration. The aim of the present work was to formulate solid lipid nanoparticles (SLNs) able to increase the skin permeation of 8-MOP. For this purpose, the penetration enhancer Transcutol\u00ae P (TRC) was added to the SLN formulation. SLNs were characterized with respect to size, polydispersity index, zeta potential, entrapment efficiency, morphology, stability, and biocompatibility. Finally, 8-MOP skin diffusion and distribution within the skin layers was investigated using Franz cells and newborn pig skin. Freshly prepared nanoparticles showed spherical shape, mean diameters ranging between 120 and 133 nm, a fairly narrow size distribution, highly negative \u03b6 potential values, and high entrapment efficiency. Empty and loaded formulations were almost stable over 30 days. In vitro penetration and permeation studies demonstrated a greater 8-MOP accumulation in each skin layer after SLN TRC 2% and TRC 4% application than that after SLN TRC 0% application. Finally, the results of experiments on 3T3 fibroblasts showed that the incorporation of TRC into SLNs could enhance the cellular uptake of nanoparticles, but it did not increase their cytotoxicity.<\/jats:p>","DOI":"10.3390\/pharmaceutics12100973","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T05:45:51Z","timestamp":1602913551000},"page":"973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Transcutol\u00ae P Containing SLNs for Improving 8-Methoxypsoralen Skin Delivery"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-2148","authenticated-orcid":false,"given":"Giulia","family":"Pitzanti","sequence":"first","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-9364","authenticated-orcid":false,"given":"Antonella","family":"Rosa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, SS 554, Km 4.5, 09042 Monserrato, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Nieddu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, SS 554, Km 4.5, 09042 Monserrato, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Valenti","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Pireddu","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2788-7823","authenticated-orcid":false,"given":"Maria Cristina","family":"Cardia","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Fadda","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8383-5895","authenticated-orcid":false,"given":"Chiara","family":"Sinico","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Unit of Drug Sciences, University of Cagliari, 09124 Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"ref_1","first-page":"319","article-title":"Psoriasis\u2014Pathophysiology, conventional, and alternative approaches to treatment","volume":"12","author":"Traub","year":"2007","journal-title":"Altern. Med. Rev."},{"key":"ref_2","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejps.2016.10.025","article-title":"Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis","volume":"96","author":"Doppalapudi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(03)00041-X","article-title":"Current concepts in psoriasis and its treatment","volume":"99","author":"Burden","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/IJN.S191940","article-title":"Microemulsions vs chitosan derivative-coated microemulsions for dermal delivery of 8-methoxypsoralen","volume":"14","author":"Wu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-3659(00)00309-6","article-title":"Microemulsions for topical delivery of 8-methoxsalen","volume":"69","author":"Baroli","year":"2000","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1773-2247(06)50017-6","article-title":"Cutaneous delivery of 8-methoxypsoralen from liposomal and niosomal carriers","volume":"16","author":"Sinico","year":"2006","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijpharm.2016.12.018","article-title":"Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition","volume":"517","author":"Kassem","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1166\/jbn.2008.342","article-title":"Nanoemulsions as Vehicle for Topical 8-Methoxypsoralen Delivery","volume":"4","author":"Lai","year":"2008","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.05.053","article-title":"Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin","volume":"547","author":"Oliveira","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jddst.2019.02.033","article-title":"Edge activated ultradeformable liposomes of psoralen and its derivatives: Development and comparative evaluation for vitiligo therapy","volume":"52","author":"Mahira","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Madigan, L.M., and Lim, H.W. (2016). Psoralen-Ultraviolet Light A Therapy, Elsevier.","DOI":"10.1016\/B978-0-323-44797-3.00003-7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jaad.2009.12.054","article-title":"A review of phototherapy protocols for psoriasis treatment","volume":"64","author":"Lapolla","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guimar\u00e3es, K.L., and R\u00e9, M.I. (2011). Lipid nanoparticles as carriers for cosmetic ingredients: The first (SLN) and the second generation (NLC). Nanocosmetics and Nanomedicines, Springer.","DOI":"10.1007\/978-3-642-19792-5_5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejpb.2010.12.010","article-title":"Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction","volume":"78","author":"Manconi","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chemphyslip.2017.05.001","article-title":"New insights into the antioxidant activity and cytotoxicity of arzanol and effect of methylation on its biological properties","volume":"205","author":"Rosa","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1039\/C8FO02395F","article-title":"Dietary zerumbone from shampoo ginger: New insights into its antioxidant and anticancer activity","volume":"10","author":"Rosa","year":"2019","journal-title":"Food Funct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.chemphyslip.2015.08.017","article-title":"Monoolein-based cubosomes affect lipid profile in HeLa cells","volume":"191","author":"Rosa","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"ref_20","unstructured":"Tscharnuter, W. (2006). Photon correlation spectroscopy in particle sizing. Encyclopedia of Analytical Chemistry, Brookhaven Instruments Corporation."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"313081","DOI":"10.1155\/2013\/313081","article-title":"Detection Limits of DLS and UV-Vis Spectroscopy in Characterization of Polydisperse Nanoparticles Colloids","volume":"2013","author":"Tomaszewska","year":"2013","journal-title":"J. Nanomater."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1208\/pt0804094","article-title":"Newborn pig skin as model membrane in in vitro drug permeation studies: A technical note","volume":"8","author":"Cilurzo","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"ref_23","first-page":"133","article-title":"Investigation of newborn pig skin as an in vitro animal model for transdermal drug delivery","volume":"13","author":"Songkro","year":"2004","journal-title":"STP Pharma Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2012.05.046","article-title":"Idebenone-loaded solid lipid nanoparticles for drug delivery to the skin: In vitro evaluation","volume":"434","author":"Montenegro","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/1061186X.2015.1070855","article-title":"Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: Formulation optimization, in vitro evaluation and preclinical assessment","volume":"24","author":"Garg","year":"2016","journal-title":"J. Drug Target."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5138\/ijdd.2010.0975.0215.02025","article-title":"Methoxsalen loaded chitosan coated microemulsion for effective treatment of psoriasis","volume":"2","author":"Behera","year":"2010","journal-title":"Int. J. Drug Deliv."},{"key":"ref_27","first-page":"140","article-title":"Microemulsion based hydrogel formulation of methoxsalen for the effective treatment of psoriasis","volume":"4","author":"Sah","year":"2011","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_28","first-page":"13","article-title":"Formulation, development and characterization of nanostructured lipid carrier (NLC) loaded gel for psoriasis","volume":"5","author":"Shinde","year":"2013","journal-title":"Pharm. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., and Maibach, H.I. (2015). Transcutol\u00ae (Diethylene Glycol Monoethyl Ether): A potential penetration enhancer. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer.","DOI":"10.1007\/978-3-662-47039-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1039\/C5TX00078E","article-title":"Effects of monoolein-based cubosome formulations on lipid droplets and mitochondria of HeLa cells","volume":"4","author":"Falchi","year":"2015","journal-title":"Toxicol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2007.07.012","article-title":"Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells","volume":"348","author":"Yuan","year":"2008","journal-title":"Int. J. Pharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/10\/973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:21:43Z","timestamp":1760178103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/10\/973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["pharmaceutics12100973"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics12100973","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}